These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16719630)

  • 1. Visual selective attention in Parkinson's disease: dissociation of exogenous and endogenous inhibition.
    Grande LJ; Crosson B; Heilman KM; Bauer RM; Kilduff P; McGlinchey RE
    Neuropsychology; 2006 May; 20(3):370-82. PubMed ID: 16719630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orienting of attention and Parkinson's disease: tactile inhibition of return and response inhibition.
    Poliakoff E; O'Boyle DJ; Moore AP; McGlone FP; Cody FW; Spence C
    Brain; 2003 Sep; 126(Pt 9):2081-92. PubMed ID: 12876143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unimpaired negative but enhanced positive priming in Parkinson's disease: evidence from an identity and a location priming task.
    Troche SJ; Trenkwalder C; Morelli-Canelo M; Gibbons H; Rammsayer TH
    Neuropsychologia; 2006; 44(10):1811-21. PubMed ID: 16620885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustments of conflict monitoring in Parkinson's disease.
    Bonnin CA; Houeto JL; Gil R; Bouquet CA
    Neuropsychology; 2010 Jul; 24(4):542-6. PubMed ID: 20604628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of visual, auditory, and mixed cues on choice reaction in Parkinson's disease.
    Akamatsu T; Fukuyama H; Kawamata T
    J Neurol Sci; 2008 Jun; 269(1-2):118-25. PubMed ID: 18279895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To the influence of general slowing and medication on identity- and location-based priming effects in patients with Parkinson's disease.
    Troche SJ; Trenkwalder C; Morelli-Canelo M; Gibbons H; Rammsayer TH
    J Neuropsychol; 2009 Sep; 3(Pt 2):147-68. PubMed ID: 19338711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course of masked response priming and inhibition in Parkinson's disease.
    Seiss E; Praamstra P
    Neuropsychologia; 2006; 44(6):869-75. PubMed ID: 16226283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of the nature of attentional deficits in patients with Parkinson's disease: evidence from a spatial orienting task.
    Filoteo JV; Delis DC; Salmon DP; Demadura T; Roman MJ; Shults CW
    J Int Neuropsychol Soc; 1997 Jul; 3(4):337-47. PubMed ID: 9260443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the basal ganglia in the control of automatic visuospatial attention.
    Fielding J; Georgiou-Karistianis N; White O
    J Int Neuropsychol Soc; 2006 Sep; 12(5):657-67. PubMed ID: 16961947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; Koerts J; Borg M; Leenders KL; van Laar T
    Mov Disord; 2008 Oct; 23(13):1906-12. PubMed ID: 18709671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basal ganglia and inhibitory mechanisms in response selection: evidence from subliminal priming of motor responses in Parkinson's disease.
    Seiss E; Praamstra P
    Brain; 2004 Feb; 127(Pt 2):330-9. PubMed ID: 14645146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distractibility with advancing age and Parkinson's disease.
    Machado L; Devine A; Wyatt N
    Neuropsychologia; 2009 Jun; 47(7):1756-64. PubMed ID: 19397871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual object recognition deficits in early Parkinson's disease.
    Laatu S; Revonsuo A; Pihko L; Portin R; Rinne JO
    Parkinsonism Relat Disord; 2004 Jun; 10(4):227-33. PubMed ID: 15120097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive impairment in Parkinson's disease: response automaticity and task switching.
    Cameron IG; Watanabe M; Pari G; Munoz DP
    Neuropsychologia; 2010 Jun; 48(7):1948-57. PubMed ID: 20303998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated time-course of inhibition of return in Huntington's disease.
    Fielding J; Georgiou-Karistianis N; Bradshaw J; Millist L; Churchyard A; White O
    Behav Brain Res; 2006 Jan; 166(2):211-9. PubMed ID: 16153717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Backward inhibition in Parkinson's disease.
    Fales CL; Vanek ZF; Knowlton BJ
    Neuropsychologia; 2006; 44(7):1041-9. PubMed ID: 16343559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural correlates of spatial and non-spatial inhibition of return (IOR) in attentional orienting.
    Zhou X; Chen Q
    Neuropsychologia; 2008 Sep; 46(11):2766-75. PubMed ID: 18597795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.